lobbying_activities: 3151264

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3151264	d91155cc-b766-47ce-856c-21572f853601	Q1	OREGON HEALTH & SCIENCE UNIVERSITY	30291	OREGON HEALTH & SCIENCE UNIVERSITY	2024	first_quarter	PHA	Support for 340B Drug Discount Program and resulting patient and community benefits provided through participating safety-net hospitals and other covered entities; opposition to imposing administrative burden to the program through new mandatory reporting requirements beyond regular HRSA audits, and policy limiting the scope and drug discounts provided under of the program; and support for Congressional and/or Administration action to prohibit pharmaceutical manufacturer denials of 340B drug discounts to safety-net hospitals and other 340B covered entities.	HOUSE OF REPRESENTATIVES,SENATE		60000	0	0	2024-04-18T13:10:23-04:00